Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Unsupported off-label chemotherapy in metastatic colon cancer

  • Jonas A de Souza1, 2Email author,
  • Blase Polite1, 2, 3,
  • Monica Perkins4,
  • Neal J Meropol5,
  • Mark J Ratain1, 2, 6,
  • Lee N Newcomer4 and
  • G Caleb Alexander7
BMC Health Services Research201212:481

DOI: 10.1186/1472-6963-12-481

Received: 2 May 2012

Accepted: 26 December 2012

Published: 29 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 May 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Jul 2012 Reviewed Reviewer Report - Axel Grothey
9 Aug 2012 Reviewed Reviewer Report - Veena Shankaran
22 Sep 2012 Author responded Author comments - Jonas de Souza
Resubmission - Version 3
22 Sep 2012 Submitted Manuscript version 3
Publishing
26 Dec 2012 Editorially accepted
29 Dec 2012 Article published 10.1186/1472-6963-12-481

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Section of Hematology/Oncology, The University of Chicago Medicine
(2)
Comprehensive Cancer Center, The University of Chicago Medicine
(3)
Center for Interdisciplinary Health Disparities Research, The University of Chicago Medicine
(4)
UnitedHealthcare
(5)
Division of Hematology and Oncology, University Hospitals Case Medical Center Seidman Cancer Center, Case Western Reserve University, Case Comprehensive Cancer Center
(6)
Committee on Clinical Pharmacology and Pharmacogenomics and Center for Personalized Therapeutics, The University of Chicago
(7)
Section of General Medicine and Center for Health and the Social Sciences, University of Chicago

Advertisement